✦ LIBER ✦

In Vitro and In Vivo Potency of Moxifloxacin and Moxifloxacin Ophthalmic Solution 0.5%, A New Topical Fluoroquinolone

✍ Scribed by David W. Stroman; Joseph J. Dajcs; Gale A. Cupp; Barry A. Schlech

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Aqueous penetration of moxifloxacin 0.5%

✍ Junko Yoshida; Alisa Kim; Kimberly A. Pratzer; Walter J. Stark 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Aqueous Penetration and Biological Activ

✍ Dianne H. Kim; Walter J. Stark; Terrence P. O’Brien; James D. Dick 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 229 KB

A comparison of moxifloxacin and levoflo

✍ Regis P. Kowalski; Eric G. Romanowski; Francis S. Mah; Hiroshi Sasaki; Masamichi 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 144 KB

Clinical Safety of Moxifloxacin Ophthalm

✍ Lewis H. Silver; Adrienne M. Woodside; Dawnelle B. Montgomery 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Correlation between in vitro and in vivo

✍ Lorena Huelves; David Sevillano; Carmina Martínez-Marín; María Teresa López-Casl 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 172 KB

The effects of moxifloxacin ophthalmic s

✍ K. Keven Williams; Mitchell D. McCartney; Rebecca L. Rice; Martin B. Wax; Joseph 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB